Vertex Pharmaceuticals Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $4.85B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Stock Repurchases | $2.02B | 41.6% |
| Other Financing | $243.9M | 5.0% |
| Working Capital | $1.22B | 25.1% |
| Other | $854.5M | 17.6% |
| Net Cash Flow | $515.6M | 10.6% |